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We report the case of a 25-year-old women suﬀering from major depression who was treated with citalopram for several weeks
with doses between 20mg and 60mg. She gradually developed marked mydriasis within 2 months after treatment and sub-
sequently neuritis nervi optici. Moreover, abrupt galactorrhea occurred after 2 months of treatment. All neuro-ophthalmologi-
cal, neurophysiological, clinical laboratory, and neuroradiological diagnostic eﬀorts did not reveal an underlying organic patho-
physiology.Theocularsymptomsdisappearedrapidlyafterthediscontinuationofcitalopramandpulsetherapywithmethyl-pred-
nisolone. However, galactorrhea persisted for a few weeks necessitating treatment with bromocriptine.
1.Introduction
Anisocoria and mydriasis are neurological symptoms which
necessitate immediate medical attention including neurolog-
ical, ophthalmological, and neuroradiological diagnostics.
Brain stem lesions, cranial nerve damage, or even brain
tumors may be possible underlying conditions. Moreover,
Adie syndrome may cause mydriasis in combination with
weak reﬂex responses and provoke diagnostic pitfalls. Aniso-
coria and mydriasis or related ocular ﬁndings following
intake of SSRIs (selective serotonin reuptake inhibitors) are
rare side eﬀects, and only few cases are documented in sci-
entiﬁc literature. Okzan and Kivrak [1] published the case
of 24-year-old nurse who developed anisocoria after one-
month treatment with sertraline. Dorell et al. [2]o b s e r v e d
acaseofdiplopiaaftertherapeuticuseofcitalopram.Already
in 1994, Barrett published one case of anisocoria associated
with administration of sertraline [3]. Obviously, anisocoria
appears to be a very rare side eﬀect occurring during
clinical use of paroxetine [4] so that a class eﬀect of SSRIs
cannot be excluded. Whereas maculopathy appears to be
very rare side eﬀect during treatment with citalopram [5]
dopamine-mediated galactorrhea is occasionally associated
with citalopram, escitalopram and other SSRIs [6–9].
We present the case of a 25-year-old women who devel-
oped a trias of marked mydriasis, neuritis nervi optici, and
ﬁnally galactorrhea after treatment with citalopram.
2.CaseReport
The 25-year-old, slightly overweighted women for the ﬁrst
time suﬀered from increasing depression in summer 2008.
Possible trigger factors were the work on a ward of apallic
patients, a new partnership, and the move to a new
apartment. In October, she consulted a psychiatrist, her
psychopathology corresponding to a moderate depression
(ICD 10 F32.1). Due to ineﬀectiveness of opipramol (max-
imum dose 2∗50mg) citalopram outpatient-treatment was
added with increasing doses (20 to 60mg). Although the
depression symptoms improved slightly, she was admitted to
the psychiatric ward due to undulating mood in November
2008.Duringtheinterview,sheshowedamoderate-to-severe
depressionwithsomaticsyndromewithoutsuicidalideation.
Due to disturbed sleep, zolpidem (5mg) was administered
transiently, and after a few days after admission, mirtazapine
with increasing doses (15 up to 30mg) was initiated.
In the neurological examination on admission she
showed a marked mydriasis with normal reaction to light2 Case Reports in Medicine
stimuli. Moreover, the patient complained of intermittenl
paraesthesias and dysaesthesias particularly in both arms
and left sided headaches. An ophthalmologist was con-
sulted the same day and diagnosed a left-sided acute optic
neuritis with paracentral scotoma. We immediately started
an intravenous pulse treatment with methyl-prednisolone
(initially 1g for 3 days, then oral dose reduction step
by step with 10 days). Simultaneously, neurological and
cardiologic was initiated to assess inﬂammatory or ischemic
brain disorders within 5 days. Thorough electrophysiological
investigations including visual evoked potentials, cMRT,
clinical laboratory, and cerebral spinal ﬂuid analysis did
not indicate an inﬂammatory brain disorder or ischemia.
Blood coagulation tests were within normal range. Neu-
rosonography showed physiological extra- and intracranial
vessels. Echocardiographic investigations (TTE and TEE)
conﬁrmed a very small PFO which had probably no clinical
relevance,butlow-doseAspirin(100mg)wasrecommended.
Gynecological assessment revealed normal ﬁndings apart
from left sided lactation; prolactin was not increased.
The patient responded well to steroid pulse therapy but
temporarily tended towards increased blood glucose levels
and ankle edema occurred. Blood glucose normalized after
cessation of steroid treatment and edema disappeared after
small doses of frusemide.
3. Discussion and Conclusion
The patient presented is the ﬁrst case in the literature suﬀer-
ing simultaneously from the trias of marked mydriasis, optic
neuritis, and galactorrhea. The exact mechanism of action
remains speculative, but some eﬀects have been already
observed experimentally or clinically. Mydriasis obviously
can be explained via 5-HT1a-receptor stimulation [10].
Optic neuritis may be caused by several drugs such as
isoniazid or ethambutol, but only in very rare cases follow-
ing administration of SSRIs [11]. Acute allergic reactions
occurred after the administration of escitalopram and may,
therefore, serve as a suitable pathophysiological model
although the course was much more delayed and less
severe in our patient [12]. Experimental data using arthritis
models in rats discuss a proinﬂammatory role of central
serotonin which indicates an aggravating eﬀect of SSRIs with
regard to the inﬂammation cascade [13]. This experimen-
tal ﬁndings were only partially conﬁrmed by population-
based determinations of C-reactive protein (CRP), which
revealed increased CRP levels only after use of tricyclic
antidepressants but not after intake of SSRIs [14]. However,
the results are equivocal, as ﬂuoxetine obviously ameliorates
neuropathic or inﬂammatory pain conditions [15].
Mydriasis, possibly due to brain activating properties of
serotonin, has been conﬁrmed in healthy volunteers [16].
Galactorrheaoccurred in patients during treatmenttricyclics
(imipramine) or SSRI (escitalopram) without depending
on increased prolactin levels [17]. Euprolactinemic galac-
torrhea is discussed as the result of indirect inhibition of
tuberoinfundibular dopaminergic neurons. On the contrary,
hyperprolactinemia and subsequent galactorrhea has also
been observed during treatment with citalopram [8].
In conclusion, the exact underlying toxicological mech-
anism of optic neuritis in our patient, however, remains to
be elucidated. With regard to galactorrhea, altered hypotha-
lamic dopamine availability may be responsible for the side
eﬀect. A general CNS-stimulating eﬀect of serotonin may
be the cause of mydriasis following intake of SSRIs. Ocular
and endocrinological symptoms only rarely occur during
treatment with SSRIs but should be taken into consideration
should the patient have corresponding complaints.
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